[HTML][HTML] Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis

M Nazarzadeh, Z Bidel, D Canoy, E Copland, M Wamil… - The Lancet, 2021 - thelancet.com
Background Blood pressure lowering is an established strategy for preventing microvascular
and macrovascular complications of diabetes, but its role in the prevention of diabetes itself …

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data …

M Nazarzadeh, Z Bidel, D Canoy… - The Lancet Diabetes & …, 2022 - thelancet.com
Background Controversy exists as to whether the threshold for blood pressure-lowering
treatment should differ between people with and without type 2 diabetes. We aimed to …

Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis

CA Emdin, K Rahimi, B Neal, T Callender, V Perkovic… - Jama, 2015 - jamanetwork.com
Importance Lowering blood pressure (BP) is widely used to reduce vascular risk in
individuals with diabetes. Objective To determine the associations between BP–lowering …

Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses

M Brunström, B Carlberg - bmj, 2016 - bmj.com
Objective To assess the effect of antihypertensive treatment on mortality and cardiovascular
morbidity in people with diabetes mellitus, at different blood pressure levels. Design …

Antihypertensive therapy and incidence of type 2 diabetes: a systematic review

R Padwal, A Laupacis - Diabetes care, 2004 - Am Diabetes Assoc
OBJECTIVE—To systematically review the available evidence examining the effects of the
major antihypertensive drug classes on the incidence of type 2 diabetes. RESEARCH …

Combined high blood pressure and glucose in type 2 diabetes: double jeopardy: British trial shows clear effects of treatment, especially blood pressure reduction

CE Mogensen - BMJ, 1998 - bmj.com
More than three decades ago Harry Keen pin-pointed two “bad companions” to diabetes:
high blood glucose concentrations and high blood pressure, both associated with …

Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?

A Zanchetti, LM Ruilope - Journal of hypertension, 2002 - journals.lww.com
Background Patients with type-2 diabetes have a high prevalence of hypertension and show
an elevated incidence of cardiovascular events and nephropathy. Objectives Recent …

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

D Ettehad, CA Emdin, A Kiran, SG Anderson… - The Lancet, 2016 - thelancet.com
Background The benefits of blood pressure lowering treatment for prevention of
cardiovascular disease are well established. However, the extent to which these effects …

Hypertension in people with type 2 diabetes: Update on pharmacologic management

NRC Campbell, RE Gilbert, LA Leiter… - Canadian Family …, 2011 - cfp.ca
Objective To summarize the evidence for the need to improve pharmacologic management
of hypertension in people with type 2 diabetes and to provide expert advice on how blood …

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual …

K Rahimi, Z Bidel, M Nazarzadeh, E Copland, D Canoy… - The Lancet, 2021 - thelancet.com
Background The effects of pharmacological blood pressure lowering at normal or high-
normal blood pressure ranges in people with or without pre-existing cardiovascular disease …